Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 21Breast Neoplasms 6Prostate Adenocarcinoma 2Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia 1Hormone Sensitive Prostate Cancer 1Granulosa cell tumor of the ovary 1Castration-resistant Prostate Cancer Patients with Oligometastases 1Breast Neoplasms, Male 1

Interventions

Paclitaxel 2Doxorubicin 2Cyclophosphamide 2pegfilgrastim 1exemestane 1Trastuzumab 1Taxes 1Tamoxifen 1Psychiatric Rehabilitation 1Mental Status and Dementia Tests 1Leuprolide 1Letrozole 1Immunotherapy 1Goserelin 1Everolimus 1Docetaxel 1Carboplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms, Male × Leuprolide × Clear all
NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡